boehringer glp-1 therapies: a new frontier in MASH treatment GLP-1 use tripled among non-diabetics,

Conclusions These findings inform and contextualize future studies assessing cardiorenal outcomes for these and additional treatments, including finerenone, for individuals with CKD and type 2 diabetes

Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer

Causes Mutations in the GSS gene cause glutathione synthetase deficiency

Acknowledgments The trials included in this analysis, and the analysis reported here, were funded by Novo Nordisk A/S

Nardi, J

This may be due to creatine helping to increase* the energy* available to muscles* during exercise, helping to reduce injuries that occur during training